Fabrinet (FN) Stock Price
FNStock
$363.51−11.87%52W
Market Cap$13.03B
P/E27.54x
PEG Ratio1.02
Div yield—
Beta1.35
FN Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-56.58%
Price vs S&P 500 (4W)-8.15%
PEG Ratio1.02
VGM Score47.39
P/E Ratio (Annual)27.54x
FN Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $3.81 | $4.10 | +7.48%(+$0.29) | |
| Q1 2026 | $3.56 | $3.72 | +4.42%(+$0.16) | |
| Q4 2025 | $3.25 | $3.36 | +3.37%(+$0.11) | |
| Q3 2025 | $2.82 | $2.92 | +3.60%(+$0.10) | |
| Q2 2025 | $2.63 | $2.65 | +0.78%(+$0.02) |
FN Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.00
4.00
4.00
4.05
Industry Peers — Telephone Equipment(8)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth (5Y) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
FNFabrinet | C | B | D | 27.5x | 19.8% | 10.0% | 21.0% | $363.51 |
| CIENCiena Corporation | D | C | B | 382.6x | 6.2% | 12.2% | 22.8% | $332.73 |
| ADTNADTRAN Holdings, Inc. Common Stock | B | B | D | — | 16.4% | -0.2% | -18.8% | $6.31 |
| CLFDClearfield, Inc. | C | C | B | — | 10.0% | 2.3% | -2.9% | $29.47 |
| AUDCAudioCodes Ltd | B | C | A | 30.0x | 11.9% | 6.2% | 4.4% | $11.20 |
| FIEEFiEE, Inc Common Stock | B | B | B | 28.2x | -30.3% | 43.0% | 59.3% | $3.55 |
| FKWLFranklin Wireless Corp. Common Stock | B | D | C | — | -27.6% | -18.9% | -14.3% | $2.25 |
| CLROClearOne, Inc. Common Stock | C | F | C | — | -14.6% | -119.9% | -285.4% | $2.99 |
| SONMDNA X, Inc. Common Stock | A | D | C | — | -12.9% | -54.4% | -71.4% | $3.27 |
About Fabrinet
Fabrinet is a contract manufacturer providing optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers across optical communications, industrial lasers, automotive, medical devices, and sensors. The company offers comprehensive capabilities spanning design engineering, supply chain management, manufacturing, assembly, packaging, and testing. Revenue is primarily generated from North America and Asia-Pacific, with additional contribution from Europe.